Dr. Amir Belson, M.D., is the founder of multiple medical device companies, including Neoguide Systems, Vascular Pathway, Zipline Medical, Qool Therepeutics, Radiaction Medical, Embolibe, Modular Surgical, and PAFA. Several of these companies have been acquired by major players in the medical device industry, including C.R. Bard and Stryker. Dr. Belson serves on the Board of Directors for Rambam MedTech Ltd., Plantera Lab, Relimetrics, and QT Vascular. A cum laude graduate of The Ruth & Bruce Rappaport Faculty of Medicine, Technion–Israel Institute of Technology, in Haifa, Israel, Belson completed a pediatric residency at Dana Children’s Hospital in Tel Aviv and a pediatric nephrology fellowship at Lucile Packard Children’s Hospital at Stanford University, California, USA. In addition, he spent one year as a research fellow with the Bio-Design Innovation Program at Stanford. Belson is the author of 34 medical papers and abstracts and has more than 500 issued and pending patents to his credit.